We have experienced two cases (Case 1: 21-year-old female, Case 2: 26-year-old female) of systemic lupus erythematosus (SLE) associated with hyperthyroidism. Case 1 had been treated with methimazole (MMI) and betamethasone for approximately two years. Although thyroid function improved with the treatment, laboratory data of SLE deteriorated. She was successfully treated with betamethasone alone. Case 2, who had severe side effect (severe hemorrhage due to gastric ulcer) during prednisolone treatment for SLE, was found to have an additional hyperthyroidism. She was treated with intermittent prednisolone administration alone. Physical findings as well as laboratory data of both SLE and hyperthyroidism improved by the therapy.
In general, it is not uncommon that more than one autoimmune disease can be seen in an individual.
Hyperthyroidism is a relatively common condition in the adult female population . It is therefore interesting that only several reports so far have described coexistence of hyperthyroidism and SLE2"7. We she continues to do quite well. She married when she was 25 years old and has two normal children (a boy when she was 27 years old and a girl when she was 29 years old).
Case 2: A 26-year-old female who had been diagnosed as SLE and had been treated with prednisolone was referred to Gifu University Hospital for further treatment of SLE on July 7, 1977, since she had severe hematoemesis and bloody stool due to gastric ulcer which required a gastrectomy. On physical examination, she was 144 cm tall and weighed 42.5 kg. Her pulse rate was 96/ min and was regular. She had moon face but no rash was noticed. She had neither tremor nor struma. She had muscle weakness of extremities and atrophy in distal muscles of arms was noted.
Her grasping power was decreased remarkably (r; 6 kg, 1; 7.5 kg). and thyroidal 131I-uptake became normal with the use of intermittent prednisolone alone, and concomitant decrease of the ESR and titer of antinuclear antibodies as well as improvement of clinical pictures of both diseases was also observed. Thus, in Case 2 it is clear that steroid treatment alone improved clinical and laboratory data of both hyperthyroidism and SLE. The underlying mechanisms of improvement of their hyperthyroidism could be speculated upon as follows: (1) Since it has been well known that glucocorticoid suppresses the biosynthesis of immunoglobulins, the production of anti-TSH receptor antibodies which belong to immunoglobulin G class was also suppressed. (2) Glucocorticoids acted directly on thyroid gland and suppressed the overproduction of thyroid hormone. (3) Glucocorticoid is known to suppress 5'-deiodination of T417\ and thus, the production of T3 which is more potent than T4 was suppressed. However, the latter 2 possibilities are highly unlikely. Although short term (3-4 months) remission of thyrotoxicosis by large daily dose of prednisone (80-169 mg per day) treatment alone has been 18) reported ', treatment of Graves' disease with glucocorticoid alone usually does not bring healing or long-term remission. Although it is very difficult to generalize the treatment of the patients with primary hyperthyroidism associated with SLE from our two cases, two other cases similar to ours who had been successfully treated with glucocorticoid alone have been reported. (4) We have to be careful using anti-thyroid drugs in such patients, because, as could have been happened in Case 1, symptoms and laboratory data of SLE may deteriorate with he medication. 621, 1969. 3 
